Not Just Another Index.
It’s The New Generation.®
We offer specialized solutions for investors seeking exposure to New Listings - a proxy for economic growth and innovation.
New: The IPOX® High Dividend 7% Strategy
An Innovative Index Strategy
combining Income & Growth!
Upcoming Global IPOs
The IPOX® Newsletters
IPOX® in the News
IPOX® CEO Josef Schuster commented on Quantinuum’s U.S. IPO filing in Reuters’ coverage of the Honeywell-backed quantum computing company’s move toward a Nasdaq listing under QNT. Reuters said Quantinuum reported higher revenue and a wider net loss while still in early commercial growth. Schuster said, “Pursing an IPO is always the first best choice to raising money,” even for high-risk quantum deals, citing the open U.S. IPO window and strong investor endorsement of quantum-linked companies overall.
IPOX® CEO Josef Schuster commented on the strength of the U.S. IPO market in Reuters’ coverage of Applied Aerospace & Defense’s IPO filing. Reuters said the defense hardware provider posted a 24.8% revenue increase in 2025, narrowed its net loss, and plans to list on the NYSE under “AADX.” Schuster said, “The U.S. IPO market is in its best shape I have seen it since the late 1990s,” adding the recovery reflects “strong post-IPO returns” and broad deal reception.
Reuters reported that Odyssey Therapeutics reached a nearly $900 million valuation after shares rose in its Nasdaq debut. IPOX® Research Associate Lukas Muehlbauer said the trend suggests the “biotech IPO window is open again after a lackluster 2025.” He also noted, “In a biotech market where M&A remains an important exit route for recently listed companies, investors may view Glick’s history as adding to Odyssey’s appeal,” citing founder Dr. Gary D. Glick’s biotech track record.
Reuters reports Lime filed for a U.S. IPO, with IPOX® Research Associate Lukas Muehlbauer noting, “Lime’s filing reflects both a better IPO market and a stronger company profile than in the previous years.” He added, “While the underlying picture has improved meaningfully, the main caveat is that the company remains loss-making and investors will look closely at whether they can turn strong revenue numbers into more consistent profitability.” Lime plans to list on Nasdaq under “LIME.”
Reuters reports Blackstone Digital Infrastructure Trust is aiming to raise slightly over $1.7 billion in a U.S. IPO to acquire newly built data centers amid strong demand for AI-linked infrastructure. IPOX® CEO Josef Schuster is quoted on the strength of the U.S. IPO market, noting that gains in AI- and energy-related deal flow have supported sentiment and demand for new listings. The Blackstone vehicle plans to list on the NYSE under the symbol “BXDC.”
The IPOX® Update
Global IPO activity is accelerating across major regions, led by large technology, infrastructure, and consumer listings. In the U.S., Blackstone’s data center vehicle, Cerebras, Quantinuum, Lime, Odyssey, Applied Aerospace & Defense, and Tenneco highlight strong demand for AI, quantum, biotech, mobility, defense, and industrial deals. Europe is seeing London IPO plans from Barnes & Noble/Waterstones and Dangote Cement, while Asia-Pacific features major Hong Kong and Tokyo listings from Syngenta, Kunlunxin, Three-Circle, Go, Sany Heavy, and SkinKandy this year overall globally.
Global IPO activity remains active across major regions, led by large U.S. listing plans from SpaceX, Roze AI, SK Hynix, Tenneco and Pershing Square USA. Europe’s pipeline includes delayed or potential listings from RAC, Dolomiti Energia and BioMar, while Singapore is advancing dual U.S.-Singapore listing rules. In MENA, Saudi Arabia’s DABS IPO is testing investor confidence amid volatility, highlighting selective resilience despite a sharp regional slowdown in issuance across the wider GCC market.
A historic tech IPO wave is building, with giants like SpaceX, OpenAI, and Anthropic targeting a combined $3 trillion valuation, signaling a massive shift in public equities. In the U.S., Milan-based Bending Spoons preps a $20 billion listing, while the new Texas Stock Exchange targets a 2027 launch. European markets remain dynamic; Revolut eyes a staggering $200 billion valuation by 2028, and Boots explores a London float. Meanwhile, geopolitical volatility forced telecom operator Digi to postpone its Spanish debut.